GBD 2019 Stroke Collaborators (2021) Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 20(10):795–820. https://doi.org/10.1016/s1474-4422(21)00252-0
Article
CAS
Google Scholar
GBD Neurology Collaborators (2019) Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(5):459–480. https://doi.org/10.1016/S1474-4422(18)30499-X
Article
Google Scholar
Winkler AS (2020) The growing burden of neurological disorders in low-income and middle-income countries: priorities for policy making. Lancet Neurol 19(3):200–202. https://doi.org/10.1016/S1474-4422(19)30476-4
Article
ADS
PubMed
Google Scholar
World Health Organization, Draft Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031, 20 July 2023. [Online]. Available: https://www.who.int/news/item/28-04-2022-draft-intersectoral-global-action-plan-on-epilepsy-and-other-neurological-disorders-2022-2031. Accessed 20 Jan 2024
Owolabi MO, Leonardi M, Bassetti C, Jaarsma J, Hawrot T, Makanjuola AI (2022) The neurology revolution. Lancet Neurol 21(11):960–961. https://doi.org/10.1016/s1474-4422(22)00394-5
Article
PubMed
Google Scholar
Pandarinath C et al (2018) Inferring single-trial neural population dynamics using sequential auto-encoders. Nat Methods 15(10):805–815. https://doi.org/10.1038/s41592-018-0109-9
Article
CAS
PubMed
PubMed Central
Google Scholar
Défossez A, Caucheteux C, Rapin J, Kabeli O, King J-R (2023) Decoding speech perception from non-invasive brain recordings. Nat Mach Intell 5(10):1097–1107. https://doi.org/10.1038/s42256-023-00714-5
Article
Google Scholar
Gupta A, Vardalakis N, Wagner FB (2023) Neuroprosthetics: from sensorimotor to cognitive disorders. Commun Biol 6(1):14. https://doi.org/10.1038/s42003-022-04390-w
Article
PubMed
PubMed Central
Google Scholar
Hausmann D et al (2023) Autonomous rhythmic activity in glioma networks drives brain tumour growth. Nature 613(7942):179–186. https://doi.org/10.1038/s41586-022-05520-4
Article
ADS
CAS
PubMed
Google Scholar
Monje M et al (2020) Roadmap for the emerging field of cancer neuroscience. Cell 181(2):219–222. https://doi.org/10.1016/j.cell.2020.03.034
Article
CAS
PubMed
PubMed Central
Google Scholar
Winter SF et al (2023) Uniting for global brain health: where advocacy meets awareness. Epilepsy Behav 145:109295. https://doi.org/10.1016/j.yebeh.2023.109295
Article
PubMed
Google Scholar
Owolabi MO et al (2023) Global synergistic actions to improve brain health for human development. Nat Rev Neurol. https://doi.org/10.1038/s41582-023-00808-z
Article
PubMed
PubMed Central
Google Scholar
Lancet T (2021) Brain health and its social determinants. Lancet 398(10305):1021. https://doi.org/10.1016/s0140-6736(21)02085-7
Article
Google Scholar
Winter SF et al (2022) Brain health-directed policymaking: a new concept to strengthen democracy. Brookings Institution
Materializing artificial intelligence. Nature Machine Intelligence 2(11): 653, 2020 https://doi.org/10.1038/s42256-020-00262-2
Rajpurkar P, Chen E, Banerjee O, Topol EJ (2022) AI in health and medicine. Nat Med 28(1):31–38. https://doi.org/10.1038/s41591-021-01614-0
Article
CAS
PubMed
Google Scholar
Wang H et al (2023) Scientific discovery in the age of artificial intelligence. Nature 620(7972):47–60. https://doi.org/10.1038/s41586-023-06221-2
Article
ADS
CAS
PubMed
Google Scholar
Bommasani R et al (2021) On the opportunities and risks of foundation models, arXiv [cs.LG], 2021/8/16. [Online]. Available: http://arxiv.org/abs/2108.07258. Accessed 20 Jan 2024
Singhal K et al (2023) Large language models encode clinical knowledge. Nature. https://doi.org/10.1038/s41586-023-06291-2
Article
PubMed
PubMed Central
Google Scholar
Tu T et al. (2023) Towards generalist biomedical ai, arXiv preprint arXiv:2307.14334.
Sudlow C et al (2015) UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 12(3):e1001779. https://doi.org/10.1371/journal.pmed.1001779
Article
PubMed
PubMed Central
Google Scholar
Zador A et al (2023) Catalyzing next-generation Artificial Intelligence through Neuro AI. Nat Commun 14(1):1597. https://doi.org/10.1038/s41467-023-37180-x
Article
ADS
CAS
PubMed
PubMed Central
Google Scholar
Hassabis D, Kumaran D, Summerfield C, Botvinick M (2017) Neuroscience-inspired artificial intelligence. Neuron 95(2):245–258. https://doi.org/10.1016/j.neuron.2017.06.011
Article
CAS
PubMed
Google Scholar
Haug CJ, Drazen JM (2023) Artificial intelligence and machine learning in clinical medicine, 2023. N Engl J Med 388(13):1201–1208. https://doi.org/10.1056/NEJMra2302038
Article
CAS
PubMed
Google Scholar
Subbiah V (2023) The next generation of evidence-based medicine. Nat Med. https://doi.org/10.1038/s41591-022-02160-z
Article
PubMed
PubMed Central
Google Scholar
Moor M et al (2023) Foundation models for generalist medical artificial intelligence. Nature 616(7956):259–265. https://doi.org/10.1038/s41586-023-05881-4
Article
ADS
CAS
PubMed
Google Scholar
Acosta JN, Falcone GJ, Rajpurkar P, Topol EJ (2022) Multimodal biomedical AI. Nat Med 28(9):1773–1784. https://doi.org/10.1038/s41591-022-01981-2
Article
CAS
PubMed
Google Scholar
Vandereyken K, Sifrim A, Thienpont B, Voet T (2023) Methods and applications for single-cell and spatial multi-omics. Nat Rev Genet. https://doi.org/10.1038/s41576-023-00580-2
Article
PubMed
PubMed Central
Google Scholar
Yang J et al (2022) DNA methylation-based epigenetic signatures predict somatic genomic alterations in gliomas. Nat Commun 13(1):4410. https://doi.org/10.1038/s41467-022-31827-x
Article
ADS
MathSciNet
CAS
PubMed
PubMed Central
Google Scholar
Roussarie J-P et al (2020) Selective neuronal vulnerability in Alzheimer’s disease: a network-based analysis. Neuron 107(5):821-835.e12. https://doi.org/10.1016/j.neuron.2020.06.010
Article
CAS
PubMed
PubMed Central
Google Scholar
US Food and Drug Administration. Rapid ASPECTS, iSchemaView, Inc. 510(k) Summary (K200760). https://www.accessdata.fda.gov/cdrh_docs/pdf20/K200760.pdf. Accessed 16 Jan 2024
Albers GW et al (2019) Automated calculation of alberta stroke program early CT score: validation in patients with large hemispheric infarct. Stroke 50(11):3277–3279. https://doi.org/10.1161/strokeaha.119.026430
Article
PubMed
Google Scholar
US Food and Drug Administration. StrokeSENS LVO, Circle Neurovascular Imaging, Inc. 510(k) Summary (K212261). https://www.accessdata.fda.gov/cdrh_docs/pdf21/K212261.pdf. Accessed 16 Jan 2024
US Food and Drug Administration. FastStroke, CT Perfusion 4D, GE Medical Systems SCS 510(k) Summary (K193289). https://www.accessdata.fda.gov/cdrh_docs/pdf19/K193289.pdf . Accessed 16 Jan 2024
US Food and Drug Administration. NeuroRPM, New Touch Digital, Inc. 510(k) Summary (K220437). https://www.accessdata.fda.gov/cdrh_docs/pdf22/K220437.pdf. Accessed 16 Jan 2024
Cognixion Inc. CXN ONE. https://one.cognixion.com/. Accessed 17 Jan 2024
Cognixion Inc. Cognixion Receives FDA Breakthrough Device Designation. https://www.cognixion.com/blog/2023/5/3/cognixion-receives-fda-breakthrough-device-designation-for-its-brain-computer-interface-with-augmented-reality-for-assistive-communication. Accessed 17 Jan 2024
Barnett M et al (2023) A real-world clinical validation for AI-based MRI monitoring in multiple sclerosis. npj Digital Med 6(1):196. https://doi.org/10.1038/s41746-023-00940-6
Article
Google Scholar
US Food and Drug Administration. Neurophet AQUA, NEUROPHET, Inc. 510(k) Summary (K203235). https://www.accessdata.fda.gov/cdrh_docs/pdf20/K203235.pdf. Accessed 16 Jan 2024.
Wang JY et al (2023) Stratified assessment of an FDA-cleared deep learning algorithm for automated detection and contouring of metastatic brain tumors in stereotactic radiosurgery. Radiat Oncol 18(1):61. https://doi.org/10.1186/s13014-023-02246-z
Article
PubMed
PubMed Central
Google Scholar
US Food and Drug Administration. Persyst 15 EEG Review and Analysis Software, Persyst Development Corporation 510(k) Summary (K222002). https://www.accessdata.fda.gov/cdrh_docs/pdf22/K222002.pdf. Accessed 16 Jan 2024.
Ganguly TM et al (2022) Seizure detection in continuous inpatient EEG: a comparison of human vs automated review. Neurology 98(22):e2224–e2232. https://doi.org/10.1212/wnl.0000000000200267
Article
PubMed
PubMed Central
Google Scholar
US Food and Drug Administration. Ceribell Status Epilepticus Monitor, Ceribell, Inc. 510(k) Summary (K223504). https://www.accessdata.fda.gov/cdrh_docs/pdf22/K223504.pdf. Accessed 16 Jan 2024.
US Food and Drug Administration. Brainscope TBI, Brainscope Company, Inc. 510(k) Summary (K190815). https://www.accessdata.fda.gov/cdrh_docs/pdf19/K190815.pdf. Accessed 16 Jan 2024.
US Food and Drug Administration. EyeBOX (Model EBX-4), Oculogica, Inc. 510(k) Summary (K212310). https://www.accessdata.fda.gov/cdrh_docs/pdf21/K212310.pdf. Accessed 16 Jan 2024.
US Food and Drug Administration. 7D Surgical System Cranial Biopsy and Ventricular Catheter Placement Application, 7D Surgical, Inc. 501(k) Summary (K192945). https://www.accessdata.fda.gov/cdrh_docs/pdf19/K192945.pdf. Accessed 17 Jan 2024.
US Food and Drug Administration. EarliPoint System, EarliTec Diagnostics, Inc. 510(k) Summary (K213882). https://www.accessdata.fda.gov/cdrh_docs/pdf21/K213882.pdf. Accessed 16 Jan 2024
US Food and Drug Administration. Cognoa ASD Diagnosis Aid, Cognoa, Inc. 510(k) Summary (DEN200069).
Comments (0)